EDS sends cat herders to the Super Bowl

Article Abstract:

Electronic Data Systems is offering a glimpse into the life of cat wranglers for their 60-second Super Bowl spot to hopefully make the audience laugh as well as appreciate the company can create order out of chaos. Fallon McElligott dreamed up the commercials which feature thousands of cats (via computer graphics) thundering through the mountains to the strains of Western movie music. EDS is spending $100 million on ads in 2000.

Advertising agencies, Radio, TV, publisher representatives, TV Advertising, Media Representatives, High technology industry, Contracts, Television advertising, Fallon McElligott, Electronic Data Systems Corp., EDS

---

New groups seek remedy to drug ads

Article Abstract:

RxHealth Value, EthicAd and other drug industry watchers are concerned about the way drug companies sell their ads on television and print. Since the 1997 FDA guidelines allowed drug sellers to market pharmaceuticals like other consumer goods, questions have arisen about full disclosure and risks to consumers. An AARP survey found that more than one-third of those questioned failed to read the small print of ads about side effects and risks. 45% said ads did not provide adequate information.

Public affairs, Ethics, Investigations, False advertising

---

Ads for controversial abortion pill set to appear in national magazines

Article Abstract:

The first national ad for mifepristone, or RU-486, is set to appear in magazines such as Glamour, Fitness, Health, People, Vanity Fair, Jane, First for Women and Mademoiselle. Redbook has declined to run the ad. The $2-million campaign, directed at consumers, is not sponsored by the drug's U.S. distributor and marketer, Danco, which is marketing the product only to physicians. The ads have been paid for by the National Abortion Federation, a professional group of abortion services, based in Washington D.C. The ad refers to the drug by name, mifepristone, and describes it as 'the Early Option pill,' but does not refer to the brand name, Mifeprex, nor to the drug's manufacturer. Neither does it list possible side effects. The NAF states that since the ad is not a pharmaceutical ad, but rather an ad run by a third party, it did not seek nor does it believe it needs F.D.A. approval for the ad. *editors note: This abstract is a replacement of the original abstract which contained false information. We apologize for any inconvenience this may have caused.*

Comment:

The National Abortion Federation has paid $2 million for magazine advertisment for RU-486, or mifepristone, an abortion pill.

Periodicals, Periodical Publishers, Social aspects, Marketing, Wholesale industry, Wholesale trade, Social policy, Political aspects, Periodical publishing, PNU, Marketing industry, Contraceptives industry, Abortion, Pharmacia Corp., Magazine advertising, National Abortion Federation

Similar abstracts:

• Abstracts: ProSports teams appeal to fans in irrelevent local ad campaigns. Amazon.com and True North part ways
• Abstracts: Novell spends $60 million to back its move into Web-services niche. Spread the Web: Cisco reaches beyond techies
• Abstracts: FCC officials signal concerns with Baby Bell mergers; U.S. could try to halt Bell Atlantic, SBC deals in the 'public interest.'
• Abstracts: Microsoft tries to lob monkey wrench into AOL-Time Warner deal. AOL faces a key test, but more lie ahead

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.